Skip navigation


Company: ImmunoGen, Inc.

ImmunoGen, Inc. : [IMGN  Loading...      ()   ]
Sep.26
6:49 PM ET
Monday, 26 Sep 2011
Daniel Junius talks to Cramer about the drug’s recent trial, which was good news for the company’s stock, and when the FDA could get it for approval.   Read More
News |  COMPANY : ImmunoGen, Inc.
Friday, 27 Jan 2012
Source: The Associated Press


Current DateTime: 09:37:17 10 Feb 2012
LinksList Documentid: 23188555



Current DateTime: 09:37:17 10 Feb 2012
LinksList Documentid: 23188557

Current DateTime: 09:37:12 10 Feb 2012
LinksList Documentid: 29778428

Current DateTime: 02:33:41 10 Feb 2012
LinksList Documentid: 29779196

Current DateTime: 11:35:13 10 Feb 2012
LinksList Documentid: 29779197

Current DateTime: 02:56:30 10 Feb 2012
LinksList Documentid: 29779199
CNBCCNBC
About CNBC  |  Site Map  |  Video Reprints   |  Advertise  |  Help  |  Contact
Privacy Policy  |     |  Terms of Service  |  Independent Programming Report
  Data is a real-time snapshot  *Data is delayed at least 15 minutes
Global Business and Financial News, Stock Quotes, and Market Data and Analysis

© 2012 CNBC LLC.  All Rights Reserved.
A Division of NBCUniversal
Thomson ReutersThomson Reuters